Core Viewpoint - The company expects a significant increase in revenue and net profit for the upcoming six months ending June 30, 2025, driven by continuous revenue growth and improved operational efficiency [1] Revenue Forecast - The company anticipates revenue between 1.9 billion to 2.047 billion RMB, representing a year-on-year growth of approximately 30% to 40% [1] Net Profit Forecast - The projected net profit is between 100 million to 110 million RMB, indicating a year-on-year increase of about 10% to 20% [1] Operational Efficiency - The growth in revenue and profit is attributed to the company's focus on refined operations and continuous efficiency improvements [1]

Major Events - Shiyao Group's (01093) application for the listing of Semaglutide injection has been accepted by the National Medical Products Administration (NMPA) [1] - Gilead Sciences-B (01672) has completed the enrollment of overweight or obese subjects in the Phase IIa study of the small molecule oral GLP-1R agonist ASC30 in the United States [1] - China Biopharmaceutical (01177) has received NMPA approval for the clinical trial application of TQC3302 "ICS/LAMA/LABA soft mist inhalation preparation" [1] - Jiaogepeng Holdings (01450) plans to acquire 100% equity of Hangzhou Jiaogepeng Education Technology Co., Ltd. for 180 million yuan [1] Financial Data - China Tower (00788) reported a mid-term profit attributable to shareholders of 5.757 billion yuan, an increase of 8.0% year-on-year, with the revenue share from its two wings business exceeding 14% [1] - Techtronic Industries (00669) reported a mid-term profit attributable to shareholders of 628 million USD, an increase of 14.17% year-on-year, with a dividend of 1.25 HKD per share [1] - Yum China (09987) reported a second-quarter operating profit of 304 million USD, a year-on-year increase of 14% [1] - Zibuyu (02420) issued a profit warning, expecting mid-term revenue to increase by approximately 30%-40% to between 1.9 billion and 2.047 billion yuan [1] - Angelalign (06699) issued a profit warning, expecting net profit for the first half of the year to be approximately 13.4 million to 14.8 million USD, a year-on-year increase of approximately 538.1% to 604.8% [1] - Boya Interactive (00434) issued a profit warning, expecting mid-term profit attributable to shareholders to decrease by approximately 25% to 35% [1] - Zhenjiu Lidu (06979) issued a profit warning, expecting mid-term net profit attributable to shareholders to decline by 23% to 24% [1] - Fourth Paradigm (06682) expects a narrowed adjusted net loss for the mid-term, down 68% to 73% year-on-year [1]

Core Viewpoint - The company expects significant revenue and profit growth for the upcoming six-month period ending June 30, 2025, driven by brand and channel development as well as operational efficiency improvements [1] Revenue Summary - The company anticipates revenue between RMB 1.9 billion and RMB 2.047 billion for the six months ending June 30, 2025, representing a year-on-year increase of approximately 30% to 40% compared to RMB 1.462 billion for the same period ending June 30, 2024 [1] Profit Summary - The projected net profit for the same period is expected to be between RMB 100 million and RMB 110 million, which indicates a year-on-year growth of approximately 10% to 20% from RMB 91.4 million for the six months ending June 30, 2024 [1] Factors Influencing Growth - The anticipated growth is attributed to two main factors: (i) deepening brand and channel development leading to sustained revenue and gross profit increases; and (ii) a focus on refined operations resulting in improved efficiency and steady profit growth [1]

Performance Summary - Techtronic Industries (00669.HK) reported a revenue of $7.8 billion for the first half of the year, an increase of 7.5% year-on-year, with a net profit of $628 million, up 14.2% [1] - Yum China (09987.HK) achieved revenue of $2.8 billion in Q2 2025, a 4% increase year-on-year, with an operating profit of $304 million, up 14% [1] - Shiseido (02145.HK) expects mid-term revenue of approximately ¥4.09-4.11 billion, a year-on-year increase of about 16.8%-17.3%, and a net profit of approximately ¥540-560 million, up about 30.9%-35.8% [1] - Prosperity Industrial Trust (00778.HK) reported revenue of approximately HK$854 million for the first half, a decrease of about 2% year-on-year, while distributable income to unitholders increased by 2.06% to HK$377 million [1] - Zibuyu (02420.HK) anticipates mid-term revenue of approximately RMB 1.9-2.047 billion, a year-on-year increase of about 30%-40%, with a net profit of approximately RMB 100-110 million, up about 10%-20% [1] - Angelalign Technology (06699.HK) expects mid-term net profit of approximately $13.4-14.8 million, a year-on-year increase of approximately 538.1%-604.8% [1] Company News - Sunac China (01918.HK) reported a cumulative contract sales amount of ¥25.08 billion for the first seven months of 2025, a decrease of 9.43% year-on-year, with July contract sales of approximately ¥1.53 billion, an increase of 8.51% [3] - Xingye Holdings (00132.HK) entered into a financing lease agreement with Heilongjiang Mudanjiang Agricultural Reclamation Xinneng Thermal Power, involving an investment of ¥100 million [3] - China Biopharmaceutical (01177.HK) received NMPA approval for the clinical trial application of TQC3302, an ICS/LAMA/LABA soft mist inhalation formulation for the maintenance treatment of chronic obstructive pulmonary disease [3] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.05 million shares at a cost of about HK$105 million, with buyback prices ranging from HK$95.35 to HK$96.3 [3] - Hang Seng Bank (00011.HK) repurchased 200,000 shares at a cost of approximately HK$22.717 million, with buyback prices between HK$113.1 and HK$114.2 [4]

Group 1 - The company expects revenue for the six months ending June 30, 2025, to be approximately RMB 1.9 billion to RMB 2.047 billion, representing a year-on-year growth of about 30% to 40% compared to RMB 1.462 billion for the six months ending June 30, 2024 [1] - The company anticipates a net profit of approximately RMB 100 million to RMB 110 million for the reporting period, which is an increase of about 10% to 20% compared to a net profit of approximately RMB 91.4 million for the six months ending June 30, 2024 [1]

Core Viewpoint - The company expects significant revenue and profit growth for the upcoming six-month period ending June 30, 2025, driven by brand and channel development as well as operational efficiency improvements [1] Revenue Summary - The company anticipates revenue between RMB 1.9 billion and RMB 2.047 billion for the six months ending June 30, 2025, representing a year-on-year increase of approximately 30% to 40% compared to RMB 1.462 billion for the same period ending June 30, 2024 [1] Profit Summary - The expected net profit for the same period is projected to be between RMB 100 million and RMB 110 million, which indicates a year-on-year growth of approximately 10% to 20% from RMB 91.4 million for the six months ending June 30, 2024 [1] Factors Influencing Growth - The anticipated growth is attributed to two main factors: (i) deepening brand and channel development leading to sustained revenue and gross profit increases; and (ii) a focus on refined operations resulting in improved efficiency and steady profit growth [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 子不語集團有限公司 呈交日期: 2025年8月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02420 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | 0.00005 | USD | | 100,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 2,000,000,000 | USD | 0.00005 | USD | | 100,000 | 本月底法定/註冊股本總額： USD 100,000 ...

（股份代號：2420） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責 ， 對其準確性或完整性亦不發表任何聲明 ，並明確表示概不會就本公告全部或任何部 分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任 。 Zibuyu Group Limited 子不語集團有限公司 （於開曼群島註冊成立的有限公司） 主席 華丙如先生 正面盈利預告 本公告由子不語集團有限公司（「本公司」，連同其附屬公司統稱為「本集團」）根據香 港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條及香港法例第 571章證券及期貨條例第XIVA部項下的內幕消息條文（定義見上市規則）而作出。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資者，基 於本集團截至2025年6月30日止六個月（「報告期間」）未經審核綜合管理賬目及董事 會目前所得資料的初步評估，本集團預計報告期間的收入將介乎約人民幣1,900百 萬元至約人民幣2,047百萬元，相比截至2024年6月30日止六個月的收入約人民幣 1,462.1百萬元，預計同比增長約30%至40%；本集團預計報告期間將錄得淨 ...

Summary of Key Points Core Viewpoint - As of July 3, a total of 120 stocks reached their 52-week highs, indicating a strong market performance with notable leaders in the list [1]. Group 1: Top Performers - The top three stocks with the highest increase rates are: - 富誉控股 (Fuyou Holdings) at 90.76%, closing at 0.435 with a peak of 0.475 [1] - 信义能源 (Xinyi Energy) at 65.00%, closing at 1.200 with a peak of 1.980 [1] - 中国三三传媒 (China San San Media) at 42.86%, closing at 1.710 with a peak of 1.900 [1] Group 2: Additional Notable Stocks - Other notable stocks include: - ITE HOLDINGS at 34.21% increase, closing at 0.047 with a peak of 0.051 [1] - 星凯控股 (Xingkai Holdings) at 30.00%, closing at 0.480 with a peak of 0.650 [1] - 北京北辰实业股份 (Beijing Beichen Industrial) at 26.47%, closing at 0.940 with a peak of 1.290 [1] Group 3: Overall Market Trends - The overall trend shows a significant number of stocks achieving new highs, reflecting positive investor sentiment and market conditions [1].

Group 1 - Southbound funds recorded a net purchase of 3.578 billion yuan today [1] - In the Hong Kong Stock Connect (Shanghai), Meituan-W and China Mobile received net purchases of 780 million HKD and 597 million HKD respectively [1] - Xiaomi Group-W had the highest net sell amount at 716 million HKD [1] Group 2 - In the Hong Kong Stock Connect (Shenzhen), Meituan-W and Horizon Robotics-W received net purchases of 295 million HKD and 182 million HKD respectively [1] - The Hang Seng China Enterprises Index had the highest net sell amount at 430 million HKD [1]